| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/12/2002 | WO2002012346A3 A new slit-like protein obtained from a cdna library from hs-5 stromal cell line |
| 09/12/2002 | WO2002008258A3 65494, a human g-protein-coupled receptor family member and uses thereof |
| 09/12/2002 | WO2002007748A3 Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor |
| 09/12/2002 | WO2001093914A3 Multivalent platform molecules comprising high molecular weight polyethylene oxide |
| 09/12/2002 | WO2001089558A3 Formulations and use of activated protein c and protein c zymogen for treating hypercoagulable states |
| 09/12/2002 | WO2001083529A3 Immunoadhesin for the prevention of rhinovirus infection |
| 09/12/2002 | WO2001081569A3 Heparanase ii, a human heparanase paralog |
| 09/12/2002 | WO2001077335A3 Listeria monocytogenes genome, polypeptides and uses |
| 09/12/2002 | WO2001071346A3 Binding compounds for cc chemokine receptor 5 and methods for identifying them |
| 09/12/2002 | WO2001049721A3 Bacterial genes and proteins that are essential for cell viability and their uses |
| 09/12/2002 | WO2001042467A3 Genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 09/12/2002 | WO2001041794A3 Activated amylase |
| 09/12/2002 | WO2001040519A3 Methods for identifying modulators for balance related disorders |
| 09/12/2002 | WO2001036626A9 Pentraxin i and pentraxin receptor, inhibitors of said proteins and pharmaceutical compositions containing said compounds |
| 09/12/2002 | WO2001035102A3 Diagnosis and treatment of malignant neoplasms |
| 09/12/2002 | WO2001034174A3 Methods for administration of therapeutic agents on an antiangiogenic schedule |
| 09/12/2002 | WO2001030848A3 Nucleic acids of the human abc1 gene and applications thereof |
| 09/12/2002 | WO2001028539A3 Agent for treating cephalic pain |
| 09/12/2002 | WO2001019852A3 Methods of peptide preparation |
| 09/12/2002 | WO2001017557A9 Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents |
| 09/12/2002 | WO2001016168A9 Induction of programmed cell death by n5 gene |
| 09/12/2002 | WO2001012651A9 Use of colostrinin, constituent peptides thereof, and analogs thereof to promote neural cell differentiation |
| 09/12/2002 | WO2001012210A9 Methods and compositions useful for modulation of angiogenesis using tyrosine kinase raf and ras |
| 09/12/2002 | WO2001010901A9 Antimicrobial histone h1 compositions, kits, and methods of use thereof |
| 09/12/2002 | WO2001010203A3 Non-human transgenic animals for the study of neurodegenerative syndromes |
| 09/12/2002 | WO2001004266A9 A lung cancer associated retrovirus, gene delivery vector and methods of use thereof |
| 09/12/2002 | WO2000073801A3 Breast, gastric and prostate cancer associated antigens and uses therefor |
| 09/12/2002 | WO2000069901A3 Proteins with insulin-like activity useful in the treatment of diabetes |
| 09/12/2002 | WO2000066176A9 Agent for gene therapy and for the prevention of metastases, as well as for the gene therapy of tumors |
| 09/12/2002 | US20020129397 Transgenic mice containing brain-specific membrane-anchored protein gene disruptions |
| 09/12/2002 | US20020129395 Compositions to identify swine genetically resistant to F18 E. coli associated diseases |
| 09/12/2002 | US20020129388 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of atherosclerosis |
| 09/12/2002 | US20020128711 Acellular matrix grafts: preparation and use |
| 09/12/2002 | US20020128683 Method and apparatus for preparing fibrinogen adhesive from whole blood |
| 09/12/2002 | US20020128599 Transdermal drug delivery devices having coated microprotrusions |
| 09/12/2002 | US20020128470 Purification process |
| 09/12/2002 | US20020128461 Orphan receptor |
| 09/12/2002 | US20020128459 Physiologically active protein originating in mammals |
| 09/12/2002 | US20020128455 Growth factors, nucleic acid encoding them and methods for identification |
| 09/12/2002 | US20020128454 CACNGLIKE3 polypeptides |
| 09/12/2002 | US20020128447 Pharmaceutical composition containing IL-10 |
| 09/12/2002 | US20020128446 Polypeptide for use in the treatment of cell proliferation and differtiation disorders |
| 09/12/2002 | US20020128444 Controling abberant inflamatory response; obtain animal, incubate with modulator of inflammation, monitor animal for adjustment in inflammatory response |
| 09/12/2002 | US20020128443 Polynucleotides encoding thrombin receptor homologs |
| 09/12/2002 | US20020128441 Endoderm, cardiac and neural inducing factors - murine frazzled (FRZB-1) protein |
| 09/12/2002 | US20020128440 Endoderm, cardiac and neural inducing factors - oligonucleotides for expressing human frazzled (frzb-1) protein |
| 09/12/2002 | US20020128439 Protein for use in tumor suppressive gene therapy |
| 09/12/2002 | US20020128438 Expression vector coding preferential protein for use in treatment of cancer; for use in gene therapy |
| 09/12/2002 | US20020128437 Polypeptide for use in the detection of bactericides and prevention, detect and treatment of infections |
| 09/12/2002 | US20020128436 Therapeutic composition for use in the treatment of autoimune and rheumatic diseases |
| 09/12/2002 | US20020128306 Programmed cell death; expansion of hematopoietic cells, for prolonging viability of an organ for transplantation, and maintaining viability of cell lines used in bioproduction |
| 09/12/2002 | US20020128304 Administering as anticarcinogenic agent |
| 09/12/2002 | US20020128294 Nicotine in therapeutic angiogenesis and vasculogenesis |
| 09/12/2002 | US20020128250 Modulating the expression of a gene |
| 09/12/2002 | US20020128239 > 1 x 10-7 mole per liter of a vitamin D compound in an acceptable lipid; anticancer agents |
| 09/12/2002 | US20020128222 Methods to enhance wound healing and enhanced wound coverage material |
| 09/12/2002 | US20020128220 Testosterone-repressed prostate message-2 (TRPM-2); delaying progression of prostatic tumor cells to an androgen-independent state |
| 09/12/2002 | US20020128219 Novel molecules of the card related protein family and uses thereof |
| 09/12/2002 | US20020128218 Therapeutic delivery compositions and methods of use thereof |
| 09/12/2002 | US20020128217 Therapeutic use of cis-element decoys in vivo |
| 09/12/2002 | US20020128216 Antisense oligonucleotides and peptide nucleic acids for treating asthma or an eosinophilic syndrome |
| 09/12/2002 | US20020128207 Dried blood factor composition comprising trehalose |
| 09/12/2002 | US20020128206 Such as 6-Amino-2-(2-((1-benzenesulfonyl-piperidine-4-carbonyl)-amino)-3-(1H-indol-3-yl)-propionylamino)-hexanoic acid tert-butyl ester for promotes secretion of growth hormone; gene expression |
| 09/12/2002 | US20020128205 Modulating nitric oxide acitivity with glutathione-dependent formaldehyde dehydrogenase (GS-FDH); for treatment of asthma and impotency, angina, hypertension, and cancer; enzyme inhibitors |
| 09/12/2002 | US20020128204 Pharmaceutical formulation for intravenous or intramuscular octreotide administration |
| 09/12/2002 | US20020128203 Methods of identifying inhibitory compounds and uses thereof |
| 09/12/2002 | US20020128202 Stimulation of bone growth with thrombin peptide derivatives |
| 09/12/2002 | US20020128201 Tumor antigen |
| 09/12/2002 | US20020128200 Method for identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of human leukocyte antigen tyrosinase derived peptides, and methods for treating said individuals |
| 09/12/2002 | US20020128199 Anti-depressant effects of corticotropin release inhibiting factor |
| 09/12/2002 | US20020128198 Novel molecules of the card-related protein family and uses thereof |
| 09/12/2002 | US20020128197 Recombinant DNA formed by ligating; gene expression; suppressing proliferation; medicine/drugs |
| 09/12/2002 | US20020128195 Hydrophilic polymer covalently and reversibly linked to amine-containing ligand through dithiobenzyl linkage; improves blood circulation time |
| 09/12/2002 | US20020128194 Method of inducing apoptosis in lymphoid cells |
| 09/12/2002 | US20020128193 Retro-inverso prosaposin-derived peptides and use thereof |
| 09/12/2002 | US20020128191 Topical administration of ophthalmic preparations of bactericidal/permeability-increasing (BPI) protein to reduce hyperemia, chemosis, mucous discharge, neovascularization or ulcer formation |
| 09/12/2002 | US20020128190 Expression of properly folded and soluble extracellular domain of a gonadotropin receptor |
| 09/12/2002 | US20020128187 Novel nucleic acids and polypeptides |
| 09/12/2002 | US20020128184 Ubiquinone composition and methods related thereto |
| 09/12/2002 | US20020128183 Gene regulation therapy involving ferritin |
| 09/12/2002 | US20020128182 Preserving a hemoglobin blood substitute with a transparent overwrap |
| 09/12/2002 | US20020128181 Administering to a patient in need of nutrition a pharmaceutical formulation comprising a source of nutrients and one or more insulinotropic peptides |
| 09/12/2002 | US20020128180 Purification method |
| 09/12/2002 | US20020128178 Use of a growth hormone or a growth hormone secretagogue for promoting bone formation in an animal simultaneous with callus distraction |
| 09/12/2002 | US20020128176 Treatment of erectile dysfunctions with C-Type natriuretic polypeptide (CNP) as a monotherapy or in combination with phosphodiesterase inhibitors |
| 09/12/2002 | US20020128175 Synthetic peptides that enhance atherogenic lipoprotein uptake and lower plasma cholesterol |
| 09/12/2002 | US20020128174 Vp22 proteins and uses thereof |
| 09/12/2002 | US20020128171 Administering to the mammal a therapeutically effective amount of a compound that increases nitric oxide (NO) activity as measured in a standard gastric emptying assay |
| 09/12/2002 | US20020127721 Polypeptide for use in the treatment of cancer or genetic disorder |
| 09/12/2002 | US20020127718 Maturation of dendritic cells by recombinant heat shock protein 70 |
| 09/12/2002 | US20020127713 Specific tolerance in transplantation |
| 09/12/2002 | US20020127702 Methods and compositions for regulating cell cycle progression |
| 09/12/2002 | US20020127698 Serpin drugs for treatment of HIV infection and method of use thereof |
| 09/12/2002 | US20020127694 2786, a novel human aminopeptidase |
| 09/12/2002 | US20020127691 Enzymatic protein for treating inflammation, thrombosis andrestenosis |
| 09/12/2002 | US20020127690 Methods and compositions for stabilizing microtubules and intermediate filaments in striated muscle cells |
| 09/12/2002 | US20020127689 Novel human galectins |
| 09/12/2002 | US20020127680 62112, a novel human dehydrogenase and uses thereof |
| 09/12/2002 | US20020127676 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 09/12/2002 | US20020127675 Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins |